期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 121, 期 8, 页码 3159-3175出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI45967
关键词
-
资金
- Research Grants Council (Hong Kong, China) [CUHK462710]
- Chinese University of Hong Kong [2041415]
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. It is more prevalent in men than women. Related to this, recent genetic studies have revealed a causal role for androgen receptor (AR) in hepatocarcinogenesis, but the underlying molecular mechanism remains unclear. Here, we used genome-wide location and functional analyses to identify a critical mediator of AR signaling cell cycle-related kinase (CCRK) - that drives hepatocarcinogenesis via a signaling pathway dependent on beta-catenin and T cell factor (TCF). Ligand-bound AR activated CCRK transcription and protein expression via direct binding to the androgen-responsive element of the CCRK promoter in human HCC cell lines. In vitro analyses showed that CCRK was critical in human cell lines for AR-induced cell cycle progression, hepatocellular proliferation, and malignant transformation. Ectopic expression of CCRK in immortalized human liver cells activated beta-catenin/TCF signaling to stimulate cell cycle progression and to induce tumor formation, as shown in both xenograft and orthotopic models. Conversely, knockdown of CCRK decreased HCC cell growth, and this could be rescued by constitutively active beta-catenin or TCF. In primary human HCC tissue samples, AR, CCRK, and beta-catenin were concordantly overexpressed in the tumor cells. Furthermore, CCRK overexpression correlated with the tumor staging and poor overall survival of patients. Our results reveal a direct AR transcriptional target, CCRK, that promotes hepatocarcinogenesis through the upregulation of beta-catenin/TCF signaling.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据